Athira Pharma, Inc. Change of Control Agreements
9 Contracts & Agreements
- Change in Control and Severance Agreement between the Company and Andrew Gengos, dated as of May 18, 2023 (Filed With SEC on May 22, 2023)
- Change in Control and Severance Agreement between the Registrant and Kevin Church (Filed With SEC on March 28, 2022)
- Amended and Restated Change in Control and Severance Agreement between the Company and Mark Litton, Ph.D (Filed With SEC on January 31, 2022)
- Change in Control and Severance Agreement between the Registrant and Mark Worthington (Filed With SEC on August 16, 2021)
- Change in Control and Severance Agreement between the Registrant and Rachel Lenington (Filed With SEC on August 16, 2021)
- Change in Control and Severance Agreement between the Registrant and Hans Moebius, Ph.D (Filed With SEC on September 14, 2020)
- Change in Control and Severance Agreement between the Registrant and Glenna Mileson (Filed With SEC on September 9, 2020)
- Change in Control and Severance Agreement between the Registrant and Mark Litton, Ph.D (Filed With SEC on September 9, 2020)
- Change in Control and Severance Agreement between the Registrant and Leen Kawas, Ph.D (Filed With SEC on September 9, 2020)
